SITE TOUR: The Hydropothecary Corp. Could Be THE Lowest Cost Producer – And They Are Pumped For Recreational Use

We recently took a trip to the fields of Gatineau QC, where The Hydropothecary Corp. (TSX.V: THCX,  OTCMKTS: HYYDF, FRA: 74H) was doing their business.  They have achieved an all-in cost per gram of just $0.89 and they expansion strategy – which is 100% built from the ground up with only Marijuana plant in mind, is quite large.  It was also a bit of a departure from other Licensed Producers when CEO Sebastien St Louis mentioned they are 95-99% focused on Recreational Use/Adult Use.  Their roots may be medical in nature, but one look at their packaging and branding reveals that they are will be aggressively attempting to seduce their potential customers.  Their branding is reminiscent of Tiffany & Co. and other high-end brands, and their QC in the operation was a reflection of that.

James West

Editor and Publisher

James West founded Midas Letter in 2008 and has since been covering the best of Canadian and US small cap companies. He covers global economics, monetary policy, geopolitical evolution, political corruption, commodities, cannabis and cryptocurrencies. As an active market participant, James is not a journalist and is invariably discussing markets...
More Info...

[email protected]

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.